Insulin Pricing Target of Class Action Lawsuit: By Joe Elia Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco,
Insulin Pricing Target of Class Action Lawsuit: By Joe Elia
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
Three companies that supply insulin in the U.S. are accused of conspiring to set increasingly higher prices for … NEJM Journal Watch.
Source: jwatch.org
RSS feed